Growth Metrics

TransMedics (TMDX) Non-Current Deffered Revenue (2018 - 2021)

TransMedics has reported Non-Current Deffered Revenue over the past 4 years, most recently at $1.6 million for Q3 2021.

  • For Q3 2021, Non-Current Deffered Revenue changed 0.43% year-over-year to $1.6 million; the TTM value through Sep 2021 reached $1.6 million, changed 0.43%, while the annual FY2020 figure was $1.6 million, 311.05% up from the prior year.
  • Non-Current Deffered Revenue for Q3 2021 was $1.6 million at TransMedics, up from $1.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $3.4 million in Q4 2018 and troughed at $389000.0 in Q4 2019.
  • A 4-year average of $1.3 million and a median of $1.5 million in 2021 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: tumbled 88.5% in 2019 and later skyrocketed 311.05% in 2020.
  • Year by year, Non-Current Deffered Revenue stood at $3.4 million in 2018, then tumbled by 88.5% to $389000.0 in 2019, then skyrocketed by 311.05% to $1.6 million in 2020, then grew by 1.06% to $1.6 million in 2021.
  • Business Quant data shows Non-Current Deffered Revenue for TMDX at $1.6 million in Q3 2021, $1.5 million in Q2 2021, and $1.6 million in Q1 2021.